and may present novel opportunities for
therapeutic intervention. This review aims to provide a
Gareev, Ilgiz,
Encarnacion Ramirez, Manuel de Jesus,
Nurmukhametov, Renat,
Ivliev, Denis,
Shumadalova, Alina,
Ilyasova, Tatiana,
Beilerli, Aferin,
Wang, Chunlei (2023) biomarkers and
therapeutic targets specifically tailored for glioma. In recent years, long non-coding RNAs
Gareev, Ilgiz,
Beylerli, Ozal,
Ahmad, Aamir,
Ilyasova, Tatiana,
Shi, Huaizhang,
Chekhonin, Vladimir (2024) the sponging of microRNAs (miRNAs) and can also be used as
therapeutic targets and biomarkers. Increasing
KHABIBOV, M.,
GARIFULLIN, A.,
KHAMITOV, F.,
KHALIKOVA, L.,
BOUMBER, Y.,
KHADDOUR, K.,
FERNANDEZ, M.,
KUZNETSOVA, N.,
KIT, O.,
KHARIN, L. (2022) into
the processes of glioblastoma pathogenesis and the discovery of
novel
therapeutic targets in novel signaling
Urakov, Aleksandr L.,
Tyurin, Anton V.,
Shchekin, Vlas S.,
Siddikov, Olim A.,
Abdurakhmanov, Ilhomjon R.,
Gabdrakhimova, Renata A.,
Samorodov, Aleksandr V. (2024) , and inflammatory diseases makes ubiquitylation of the enzymes involved a promising
target to develop new therapy
Beylerli, Ozal,
Shi, Huaizhang,
Begliarzade, Sema,
Shumadalova, Alina,
Ilyasova, Tatiana,
Sufianov, Albert (2024) metastases, offering valuable insights into underlying mechanisms and potential
therapeutic targets as both diagnostic biomarkers and
therapeutic targets for IAs. CircRNAs have demonstrated their influence
Gareev, Ilgiz,
Beylerli, Ozal,
Ilyasova, Tatiana,
Ahmad, Aamir,
Shi, Huaizhang,
Chekhonin, Vladimir (2024) -inflammatory, and trophic. This study presents data on the possibility of using SVF,
targeted regulation of its properties
, such as
therapeutic targets and non-invasive diagnostic/prognostic biomarker tools. © 2024, The Author(s).
Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) and genomics have enabled the identification of specific molecular pathways and
targets, paving the way